JP2017505621A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017505621A5 JP2017505621A5 JP2016549152A JP2016549152A JP2017505621A5 JP 2017505621 A5 JP2017505621 A5 JP 2017505621A5 JP 2016549152 A JP2016549152 A JP 2016549152A JP 2016549152 A JP2016549152 A JP 2016549152A JP 2017505621 A5 JP2017505621 A5 JP 2017505621A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- bait
- polypeptide chain
- nucleic acid
- chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461933048P | 2014-01-29 | 2014-01-29 | |
| US61/933,048 | 2014-01-29 | ||
| PCT/CA2015/000049 WO2015113140A1 (en) | 2014-01-29 | 2015-01-28 | Methods and compositions for producing a cell expressing a t cell receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017505621A JP2017505621A (ja) | 2017-02-23 |
| JP2017505621A5 true JP2017505621A5 (enExample) | 2018-03-08 |
| JP6580579B2 JP6580579B2 (ja) | 2019-09-25 |
Family
ID=53756056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549152A Active JP6580579B2 (ja) | 2014-01-29 | 2015-01-28 | Ｔ細胞受容体を発現する細胞を生産する方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10654907B2 (enExample) |
| EP (1) | EP3099708B1 (enExample) |
| JP (1) | JP6580579B2 (enExample) |
| CA (1) | CA2934729C (enExample) |
| WO (1) | WO2015113140A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12364757B2 (en) | 2015-10-01 | 2025-07-22 | Ospedale San Raffaele S.R.L | TCR and uses thereof |
| CA3008641A1 (en) | 2015-12-16 | 2017-06-22 | Gritstone Oncology, Inc. | Neoantigen identification, manufacture, and use |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| MA45491A (fr) * | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés |
| DK3491384T3 (da) * | 2016-08-01 | 2021-06-28 | Health Research Inc | Sammensætninger og fremgangsmåder til hurtig kloning af t-celle-receptorer |
| US10822662B2 (en) * | 2017-03-06 | 2020-11-03 | Karkinos Precision Oncology LLC | Diagnostic methods for identifying T-cell lymphoma and leukemia by high-throughput TCR-β sequencing |
| WO2019075112A1 (en) | 2017-10-10 | 2019-04-18 | Gritstone Oncology, Inc. | IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS |
| EP3714275A4 (en) | 2017-11-22 | 2021-10-27 | Gritstone bio, Inc. | REDUCTION OF JUNCTION EPITOPIC PRESENTATION FOR NEOANTIGENS |
| JP6821230B2 (ja) | 2019-02-04 | 2021-01-27 | 国立大学法人愛媛大学 | ＣＡＲライブラリおよびｓｃＦｖの製造方法 |
| GB202211194D0 (en) * | 2022-08-01 | 2022-09-14 | Univ College Cardiff Consultants Ltd | Novel TCRs |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1795599A1 (en) | 2005-12-09 | 2007-06-13 | Schuler, Gerold, Prof. Dr. | Methods for generating antigen-specific effector T cells |
| WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| EP3031916B1 (en) * | 2007-06-11 | 2017-06-07 | Takara Bio Inc. | Method for expression of specific gene |
| EP2352756B1 (en) * | 2008-11-24 | 2012-09-19 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | High affinity t cell receptor and use thereof |
| US9409969B2 (en) * | 2009-02-09 | 2016-08-09 | Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) | Repertoire of allo-restricted peptide-specific T cell receptor sequences and use thereof |
| EP3533802B1 (en) * | 2010-09-21 | 2021-03-17 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Anti-ssx-2 t cell receptors and related materials and methods of use |
| WO2012104843A1 (en) * | 2011-02-06 | 2012-08-09 | Yeda Research And Development Co.Ltd. At The Weizmann Institute Of Science | Affinity maturated t cell receptors and use thereof |
| WO2012154858A1 (en) * | 2011-05-09 | 2012-11-15 | Whitehead Institute For Biomedical Research | Chaperone interaction assays and uses thereof |
| WO2013177247A1 (en) * | 2012-05-22 | 2013-11-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Murine anti-ny-eso-1 t cell receptors |
-
2015
- 2015-01-28 CA CA2934729A patent/CA2934729C/en active Active
- 2015-01-28 EP EP15744002.5A patent/EP3099708B1/en active Active
- 2015-01-28 JP JP2016549152A patent/JP6580579B2/ja active Active
- 2015-01-28 WO PCT/CA2015/000049 patent/WO2015113140A1/en not_active Ceased
- 2015-01-28 US US15/111,639 patent/US10654907B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017505621A5 (enExample) | ||
| JP7439002B2 (ja) | ヒト化抗ｃｄ１９キメラ抗原受容体を使用するがんの処置 | |
| TWI710572B (zh) | 改善配對的ｔ細胞受體 | |
| KR102742220B1 (ko) | 항-hla-a2 항체 및 그 사용 방법 | |
| ES2963718T3 (es) | Capacidad presentadora de antígenos de células CAR-T potenciada mediante introducción conjunta de moléculas co-estimuladoras | |
| JP2021118723A (ja) | 免疫療法のためのマクロファージの遺伝子組換え | |
| JP2018183175A (ja) | Ｗｔ−１に特異的なｔ細胞免疫治療 | |
| KR20240028975A (ko) | Cd8-특이적 항체 구조체들 및 이의 조성물 | |
| JP2020536527A (ja) | Ｂｃｍａに結合するキメラ抗原受容体（ｃａｒ）及びその応用 | |
| KR20230152035A (ko) | 표적 단백질 분해 시스템 및 이의 응용 | |
| TW201922774A (zh) | 標靶bcma嵌合抗原受體、標靶cd19嵌合抗原受體及組合療法 | |
| JP7447014B2 (ja) | インターロイキン２３受容体に特異的なキメラ抗原受容体 | |
| TW201930591A (zh) | 用於與嵌合抗原受體療法併用之免疫增強rna | |
| EP3490590A2 (en) | Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage molecule | |
| KR20190016966A (ko) | 길항성 항-종양 괴사 인자 수용체 슈퍼패밀리 항체 | |
| CN107708710A (zh) | Smart CAR装置,DE CAR多肽,Side CAR及其使用 | |
| JP2015518479A5 (enExample) | ||
| US20230044451A1 (en) | Methods and compositions for the delivery of modified lymphocytes and/or retroviral particles | |
| CA3090249A1 (en) | Combination therapy using a chimeric antigen receptor | |
| CN120917046A (zh) | 新型cd19结合剂、包含所述cd19结合剂的car-t构建体及其使用方法 | |
| JP2023500318A (ja) | 細胞選択および／または細胞刺激デバイスならびに使用方法 | |
| WO2021074313A1 (en) | Chimeric antigen receptor specific for interleukin-23 receptor | |
| TW202300643A (zh) | 用於增強幹細胞樣記憶ｔ細胞工程改造之材料及方法 | |
| US12433954B2 (en) | Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs | |
| CN117279945A (zh) | 嵌合细胞因子受体及其在细胞疗法中的用途 |